Lazard US Equity Concntr X Acc USD |
Performance History | 31/03/2019 |
Growth of 1,000 (EUR) |
Fund | - | - | - | -2.2 | 19.1 | |
+/-Cat | - | - | - | 0.3 | - | |
+/-Idx | - | - | - | -1.9 | - | |
Category: US Large-Cap Blend Equity | ||||||
Benchmarks: Morningstar US LM NR USD |
Key Stats | ||
NAV 08/04/2019 | USD 117.98 | |
Day Change | -0.26% | |
Morningstar Category™ | US Large-Cap Blend Equity | |
ISIN | IE00BZ60K867 | |
Fund Size (Mil) 24/04/2024 | USD 165.24 | |
Share Class Size (Mil) 08/04/2019 | USD 0.00 | |
Max Initial Charge | 3.00% | |
Ongoing Charge 14/09/2020 | 0.14% |
Investment Objective: Lazard US Equity Concntr X Acc USD |
The Fund is an all-cap, concentrated fund that seeks long-term capital appreciation. It is benchmark agnostic, seeking to outperform any broad-based US index (i.e., S&P 500 Index, Russell 1000 Index, Russell 3000 Index) by investing in financially productive (e.g., high return on equity, free cash flow, cash flow return on investment) companies across the market capitalization spectrum, employing intensive fundamental analysis and accounting validation to identify investment opportunities. The Fund typically invests in 15–35 companies with market capitalizations generally greater than $350 million. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Martin Flood 25/02/2016 | ||
Jay Levy 31/03/2022 | ||
Click here to see others | ||
Inception Date 04/10/2017 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
S&P 500 NR USD | Morningstar US LM NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Lazard US Equity Concntr X Acc USD | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Laboratory Corp of America Holdings | Healthcare | 8.85 |
Alphabet Inc Class A | Communication Services | 8.11 |
Fidelity National Information Se... | Technology | 6.65 |
S&P Global Inc | Financial Services | 6.47 |
Crown Castle Inc | Real Estate | 5.86 |
Increase Decrease New since last portfolio | ||
Lazard US Equity Concntr X Acc USD |